Bivalirudin - injectable
Unknown / Multiple | Bivalirudin - injectable (Medication)
Bivalirudin is indicated as an anticoagulant in adult patients undergoing percutaneous coronary intervention (PCI), including patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI. It is also indicated for the treatment of adult patients with unstable angina/non-ST segment elevation myocardial infarction (UA/NSTEMI) planned for urgent or early intervention. Bivalirudin should be administered with aspirin and clopidogrel. ...
Nausea, vomiting, heartburn, headache, or minor bleeding/irritation at the injection site may occur. You may bleed and bruise more easily while you are using this medicine. Be extra careful to avoid injuries until the effects of the medicine have worn off. Watch for any bleeding from open areas such as around the injection site. Also check for blood in your urine or stool. If you have any bleeding or injuries, tell your doctor right away. Your doctor will need to check your blood at regular visits while you are using this medicine. ...
Make sure your doctor knows if you are pregnant or breastfeeding, or if you have a kidney problem, bleeding disorder such as hemophilia, or if you bruise easily. Tell your doctor if you are receiving brachytherapy (a radiation treatment).
Combined use of anti-coagulant medicines can be expected to increase the risk of bleeding. When bivalirudin is combined with a platelet inhibitor or an anti-coagulant medicine, clinical and biological parameters of haemostasis should be regularly monitored. ...